RecruitingPhase 3NCT05456503

PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Disease Using the PET Ligand [18F]-PI-2620


Sponsor

University of Pennsylvania

Enrollment

72 participants

Start Date

Sep 19, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators will compare \[18F\]-PI-2620 tau PET scans from patients with frontotemporal lobar degeneration (FTLD), patients with non-amnestic presentations of Alzheimer's disease (naAD), and demographically matched cognitively normal subjects.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses a specialized PET scan with a radioactive tracer called [18F]-PI-2620 to image tau protein buildup in the brains of people with frontotemporal dementia (FTD) or atypical Alzheimer's disease, as well as healthy volunteers. Tau tangles are a key feature of many dementias and being able to image them can help with diagnosis and research. **You may be eligible if...** - You are 18 years or older and enrolled in the UNICORN study at the University of Pennsylvania - You are either cognitively healthy (as a comparison participant), or have been diagnosed with frontotemporal dementia, atypical Alzheimer's disease, or a related condition - You are able to complete the required cognitive assessments and brain imaging **You may NOT be eligible if...** - You have significant claustrophobia that prevents lying in a PET scanner - You have metal implants or other contraindications to brain imaging - You are pregnant or breastfeeding - You are unable to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG[18F]-PI-2620

Radiotracer


Locations(1)

Perelman Center for Advance Medicine

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05456503


Related Trials